Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
The invention concerns genomic and cDNA sequences of the human TBC-1 gene. The invention also concerns polypeptides encoded by the TBC-1 gene. The invention also deals with antibodies directed specifically against such polypeptides that are useful as diagnostic reagents. The invention further encompasses biallelic markers of the TBC-1 gene useful in genetic analysis.
1 . An isolated, purified, or recombinant polynucleotide comprising a contiguous span of at least 60 nucleotides of SEQ ID NO:1, 2, 3, 4 and the complements thereof.
2 . The isolated, purified, or recombinant polynucleotide according to claim 1 , wherein said contiguous span of any one of SEQ ID NOs:1, 2, or the complements thereof, includes a biallelic marker that is selected from the group consisting of the biallelic markers at position 9494 of SEQ ID NO:1, position 1443 of SEQ ID NO:2, position 5247 of SEQ ID NO:2, position 6223 of SEQ ID NO:2, position 14723 of SEQ ID NO:2, position 19186 of SEQ ID NO:2, position 18997 of SEQ ID NO:2, position 19891 of SEQ ID NO:2, position 29617 of SEQ ID NO:2, position 42519 of SEQ ID NO:2, position 69324 of SEQ ID NO:2, position 69181 of SEQ ID NO:2, position 69146 of SEQ ID NO:2, position 76458 of SEQ ID NO:2, position 78595 of SEQ ID NO:2, position 82159, position 84522 of SEQ ID NO:2, position 84810 of SEQ ID NO:2, and position 89967 of SEQ ID NO:2.
3 . A composition comprising a recombinant vector comprising the isolated, purified, or recombinant polynucleotide of claim 1 .
4 . The composition according to claim 3 , wherein said composition comprises a host cell transformed with said recombinant vector.
5 . An isolated polypeptide comprising SEQ ID NO:5.
6 . A composition comprising an isolated or purified antibody composition capable of selectively binding to an epitope-containing fragment of a polypeptide comprising SEQ ID NO:5.
7 . A method of genotyping comprising the steps of:
(a) obtaining a nucleic acid sample from an individual; and
(b) determining the identity of a polymorphic base at a TBC-1-related biallelic marker or the complement thereof in said nucleic acid sample, wherein the identity of the polymorphic base determines the genotype of the individual at said TBC-1-related biallelic marker and, wherein said TBC-1-related biallelic marker is positioned in SEQ ID NO:1 or SEQ ID NO:2.
8 . The method according to claim 7 , further comprising amplifying a portion of said sequence comprising the biallelic marker prior to said determining step.
9 . The method according to claim 7 , wherein said determining is performed by a hybridization assay, sequencing assay, microsequencing assay, or enzyme-based mismatch detection assay.
10 . The method according to claim 7 , wherein said TBC-1-related biallelic marker is selected from the group consisting of the biallelic markers in positions 9494 of the SEQ ID NO:1, and 1443, 5247, 6223, 14723, 19186, 18997, 19891, 29617, 42519, 69324, 69181, 69146, 76458, 78595, 82159, 84522, 84810, and 89967 of the SEQ ID NO:2.